Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 17,600
+230 (1.32%)
Apr 10, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 1.63 trillion as of April 10, 2026. Its market cap has increased by 148.35% in one year.
Market Cap
1.63T
Enterprise Value
2.73T
Revenue
1.27T
Ranking
n/a
PE Ratio
n/a
Stock Price
17,600.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 1.63T, an increase of 387.17%. That is a compound annual growth rate of 9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 1.61T | 43.52% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK bioscience | 3.16T |
| OliX Pharmaceuticals | 3.16T |
| D&D Pharmatech | 2.94T |
| PharmaResearch | 2.94T |
| Hugel | 2.60T |
| Orum Therapeutics | 1.63T |
| Pharmicell | 873.66B |
| Onconic Therapeutics | 872.17B |